News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Lonza
NEWS
JOBS
IN THE PRESS
NEWS
Lonza Further Strengthens Hepatocytes Portfolio with Addition of Hepatic Non-Parenchymal Cells
Lonza announced the addition of hepatic stellate cells, Kupffer cells and liver-derived endothelial cells to its extensive hepatocytes portfolio.
May 22, 2018
·
4 min read
Job Trends
Active Pharmaceutical Ingredient Maker Lonza Biologics to Hire 70 in New Hampshire
August 22, 2016
·
3 min read
Deals
New Jersey’s Catalent Jumps on Rumors of Lonza Group’s Takeover Bid
April 14, 2016
·
3 min read
Lonza Group Ltd. to Offer Life Science Engineering Services in China
August 8, 2008
·
1 min read
Genetown
The Day In Review: Cambrex Corporation Sells Bio Businesses For $460 Million
October 24, 2006
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention
April 7, 2025
·
4 min read
Press Releases
TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
April 30, 2024
·
2 min read
Business
NeuroSense Collaborates with Lonza to Identify Exosome-based Biomarkers, in order to Advance Neurodegenerative Disease Treatments and Diagnostics
April 9, 2024
·
7 min read
Business
Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’s Disease
April 4, 2024
·
6 min read
Biotech Bay
Epsilogen and Lonza Announce Successful Large-Scale GMP Manufacturing of MOv18, an IgE Antibody Targeting Ovarian Cancer
March 5, 2024
·
5 min read
Job Trends
Medivir have agreed with Lonza to manufacture a fostrox GMP campaign, to be tested in 2L HCC with intent to commercialize via accelerated approval
December 13, 2023
·
2 min read
Genetown
Vertex and Lonza to Build Dedicated Manufacturing Facility for Type 1 Diabetes (T1D) Cell Therapies
June 26, 2023
·
8 min read
Business
Context Therapeutics and Lonza Enter Manufacturing Agreement for Bispecific Antibody Targeting Claudin 6-Positive Cancers
January 9, 2023
·
6 min read
Biotech Bay
Pierre Fabre and Lonza Enter Manufacturing Agreement for W0180 Antibody Drug Product
June 15, 2022
·
3 min read
Business
EV Biologics Signs MSA with LONZA Cell & Gene Therapy
May 17, 2022
·
5 min read
